Bank Of New York Mellon Corp Soleno Therapeutics Inc Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$0.97 - $1.32 $116,172 - $158,089	-119,765 Reduced 73.91%	42,270 $48,000
Q1 2021 May 13, 2021	SELL	$1.24 - $3.3 $9,828 - $26,155	-7,926 Reduced 4.66%	162,035 $204,000
Q4 2020 Feb 09, 2021	BUY	$1.61 - $2.23 $78,027 - $108,074	48,464 Added 39.89%	169,961 $328,000
Q3 2020 Nov 12, 2020	BUY	$1.71 - $2.51 $74,923 - $109,975	43,815 Added 56.4%	121,497 $304,000
Q2 2020 Aug 12, 2020	BUY	$1.77 - $4.23 $109,111 - $260,758	61,645 Added 384.39%	77,682 $172,000
Q3 2019 Nov 07, 2019	SELL	$1.5 - $2.99 $2,400 - $4,784	-1,600 Reduced 9.07%	16,037 $24,000
Q2 2019 Aug 12, 2019	BUY	$1.93 - $2.95 $34,039 - $52,029	17,637 New	17,637 $49,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $468M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.